Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN

  • Read more about RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN
US Patent 7,118,738
Filed on 2002-01-25

Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith

  • Read more about Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith
US Application 10/070,853
Filed on 2002-03-08

Calcium Channel Proteins

  • Read more about Calcium Channel Proteins
US Patent 6,979,724
Filed on 2002-04-05

Integrated Low Field MRI/RF EPRI For Co-Registering Imaging Of In Vivo Physiology And Anatomy In Living Objects

  • Read more about Integrated Low Field MRI/RF EPRI For Co-Registering Imaging Of In Vivo Physiology And Anatomy In Living Objects
US Application 10/111,726
Filed on 2002-04-26

Detecting Malignant Cells With Monoclonal Antibodies Specific to Type IV Collagenase Enzyme

  • Read more about Detecting Malignant Cells With Monoclonal Antibodies Specific to Type IV Collagenase Enzyme
US Patent 4,677,058
Filed on 1983-05-19

Use of Semenogelin in the Diagnosis, Prognosis And Treatment of Cancer

  • Read more about Use of Semenogelin in the Diagnosis, Prognosis And Treatment of Cancer
Patent Cooperation Treaty
PCT/US02/10535
Filed on 2002-04-03

METHOD AND COMPOSITIONS FOR CORRELATING CCR5 EXPRESSION WITH ESSENTIAL HYPERTENSION

  • Read more about METHOD AND COMPOSITIONS FOR CORRELATING CCR5 EXPRESSION WITH ESSENTIAL HYPERTENSION
US Application 10/110,519
Filed on 2002-04-11

Nucleic Acids For Transgene Expression

  • Read more about Nucleic Acids For Transgene Expression
Patent Cooperation Treaty
PCT/US02/10594
Filed on 2002-04-04

Geldanamycin Derivative And Method of Treating Cancer Using Same

  • Read more about Geldanamycin Derivative And Method of Treating Cancer Using Same
Patent Cooperation Treaty
PCT/US2002/010097
Filed on 2002-03-28

Utilization of FPRL1 as a Functional Receptor by Serum Amyloid A (SAA)

  • Read more about Utilization of FPRL1 as a Functional Receptor by Serum Amyloid A (SAA)
US Application 10/099,782
Filed on 2002-03-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1476
  • Page 1477
  • Page 1478
  • Page 1479
  • Page 1480
  • Page 1481
  • Page 1482
  • Page 1483
  • Page 1484
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health